help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 7, 2005
Molecular Endocrinology, doi:10.1210/me.2004-0244
Molecular Endocrinology Vol. 0, No. 2005 200402441-
doi:10.1210/me.2004-0244
Copyright © 2005 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data Files
Right arrow All Versions of this Article:
19/8/2112    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermann, B. P.
Right arrow Articles by Heckert, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermann, B. P.
Right arrow Articles by Heckert, L. L.

Submitted on June 15, 2004
Accepted on March 30, 2005

Silencing of Fshr occurs through a conserved, hypersensitive site in the first intron

Brian P. Hermann and Leslie L. Heckert*

Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160

* To whom correspondence should be addressed. E-mail: lheckert{at}kumc.edu.

Expression of the FSH receptor (Fshr) is restricted to testicular Sertoli cells and ovarian granulosa cells, thereby limiting the direct targets of FSH action to these somatic cells of the gonads. Earlier studies indicate that transcription of Fshr in the gonads requires elements outside the gene's immediate 5' flanking sequence. To help uncover candidate regulatory sequences comparative genomics and DNase I hypersensitivity mapping were employed. 156 evolutionarily conserved sequences were found and partial DNase I hypersensitivity mapping across 45kb of 5' flanking sequence and the first intron identified four hypersensitive sites, DHS#1-#4. Notably, DHS#1and DHS#2 localized to conserved sites in the promoter region and exon 1 and correlated with the active state of the gene. DHS#3 also corresponded to a conserved site (site 7) but was more pronounced in non-expressing myoid cells, suggesting a role in gene silencing. Transient transfection analysis of DHS#3 confirmed its role in gene silencing, a function that was promoter, cell-type and position dependent. Protein-DNA binding studies on DHS#3 revealed that OCT-1 and GATA-4 bound site 7, in vitro, and transient transfection analysis showed that their binding sites were required for silencing activity. Furthermore, chromatin immunoprecipitation (ChIP) revealed that OCT-1 bound to site7 in the endogenous gene, but only in myoid cells. In contrast, GATA-1 bound site7 predominantly in Sertoli cells, suggesting it attenuates silencer activity. The findings reveal that OCT-1 binds within DHS#3 to silence Fshr transcription and implicate members of the GATA family in the modulation of this activity.


Key words: Fshr • Sertoli cell • DNase I hypersensitivity mapping • comparative genomics • ChIP • GATA-1 • GATA-4 and OCT-1




This article has been cited by other articles:


Home page
EndocrinologyHome page
B. P. Hermann, K. Hornbaker, D. A. Rice, M. Sawadogo, and L. L. Heckert
In Vivo Regulation of Follicle-Stimulating Hormone Receptor by the Transcription Factors Upstream Stimulatory Factor 1 and Upstream Stimulatory Factor 2 Is Cell Specific
Endocrinology, October 1, 2008; 149(10): 5297 - 5306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society